Skip to main content
  • AACR Publications
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

  • Register
  • Log in
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Focus on Computer Resources
    • 75th Anniversary
    • Meeting Abstracts
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • OnlineFirst
    • Editors' Picks
    • Citations
    • Author/Keyword
  • News
    • Cancer Discovery News
  • AACR Publications
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in

Search

  • Advanced search
Cancer Research
Cancer Research

Advanced Search

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Focus on Computer Resources
    • 75th Anniversary
    • Meeting Abstracts
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • OnlineFirst
    • Editors' Picks
    • Citations
    • Author/Keyword
  • News
    • Cancer Discovery News
Cellular, Molecular, and Tumor Biology 109: Preclinical Science and Imaging in Cancer Models

In vivo induction of tumor-specific CTL against CEA-antigens and MAGE-3 antigens expressed on human lung adenocarcinoma by using CEA gene therapy

Masaji Okada, Takao Tanaka, Yoko Kita, Sachiko Kuwayama, Yumiko Muraki, Noriko Kanamaru, Satomi Hashimoto, Hiroko Takai, Chika Okada, Yukari Fukunaga, Yayoi Sakaguchi, Izumi Furukawa, Kyoko Yamada, Satoru Yamamoto, Akihide Matsumura, Keiji Iuchi, Masaaki Kawahara and Sakatani Mitsunori
Masaji Okada
National Kinki-chuo Hospital for Chest Diseases, Osaka, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Takao Tanaka
National Kinki-chuo Hospital for Chest Diseases, Osaka, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yoko Kita
National Kinki-chuo Hospital for Chest Diseases, Osaka, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sachiko Kuwayama
National Kinki-chuo Hospital for Chest Diseases, Osaka, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yumiko Muraki
National Kinki-chuo Hospital for Chest Diseases, Osaka, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Noriko Kanamaru
National Kinki-chuo Hospital for Chest Diseases, Osaka, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Satomi Hashimoto
National Kinki-chuo Hospital for Chest Diseases, Osaka, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hiroko Takai
National Kinki-chuo Hospital for Chest Diseases, Osaka, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Chika Okada
National Kinki-chuo Hospital for Chest Diseases, Osaka, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yukari Fukunaga
National Kinki-chuo Hospital for Chest Diseases, Osaka, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yayoi Sakaguchi
National Kinki-chuo Hospital for Chest Diseases, Osaka, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Izumi Furukawa
National Kinki-chuo Hospital for Chest Diseases, Osaka, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kyoko Yamada
National Kinki-chuo Hospital for Chest Diseases, Osaka, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Satoru Yamamoto
National Kinki-chuo Hospital for Chest Diseases, Osaka, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Akihide Matsumura
National Kinki-chuo Hospital for Chest Diseases, Osaka, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Keiji Iuchi
National Kinki-chuo Hospital for Chest Diseases, Osaka, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Masaaki Kawahara
National Kinki-chuo Hospital for Chest Diseases, Osaka, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sakatani Mitsunori
National Kinki-chuo Hospital for Chest Diseases, Osaka, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI:  Published April 2004
  • Article
  • Info & Metrics
Loading
Proc Amer Assoc Cancer Res, Volume 45, 2004

Abstract

5140

In previous study we showed synergistic effect of IL-6 related genes (IL-6 gene, IL-6 receptor gene and gp130 gene) on the induction of CTL against human cancer cells using SCID-PBL/hu experimental model. In this model IL-6 related genes were administered in vivo using adenovirus vector into SCID-PBL/hu mice bearing human cancers, and induced CTL activity against human tumor cells (lung cancer, stomach cancer, colon cancer) and significant prolonged survival of mice was observed. IL-6 related genes (IL-6 gene+IL-6 receptor(R) gene+gp130 gene) were injected intraperitoneally(i-p) into SCID-PBL/hu mice in vivo by using this experimental model (SCID mice given PBL from lung cancer patient and autologous lung cancer cells). Furthermore, the in vivo generation of human CTL against MAGE-3 peptide (9 amino acids) when SCID-PBL/hu were treated with the MAGE-3 peptide capable of binding HLA-A24 and IL-6 related genes. The human CTL activity generated in vivo from spleen cells, mesenteric lymph node cells and peritoneal exudate cells (PEC) in these SCID-PBL/hu mice was exerted against the human target cells expressed HLA-A24, but not HLA-A2. Furthermore, the in vivo human CTL against CEA antigen were generated when SCID-PBL/hu were treated with CEA genes by using adenovirus vector. The human CD8 positive CTL activity generated in vivo from spleen cells in these SCID-PBL/hu mice was exerted against the human CEA- positive tumor cells expressed the same HLA- A24 as the donor of human PBL possessed. Therefore, it was demonstrated that these human CTL generated in vivo in SCID-PBL/hu mice were antigen specific and HLA-restricted. To our knowledge, it is quite difficult to generate the in vivo CTL against tumor associate antigens in human treated with several kinds of cancer vaccines (tumor associated antigens vaccines). MAGE-3 antigens and CEA antigens were expressed on 30∼40% of human lung cancers and almost of lung adenocarcinoma in Japan. Therefore, the SCID-PBL/hu model using CEA gene or peptides of tumor associated antigens might provide a powerful weapon for developing new cancer vaccines against human lung cancers. (Co-worker: Kazuto Takesako: Takara-shuzo Central Institute, Izumu Saito: Tokyo University) (Grant sponsor: Ministry of Health Labor and Welfare, Japan (Second Term Comprehensive 10-year Strategy for Cancer Control: Grant number: H-14gan-033)

  • American Association for Cancer Research
Previous
Back to top
April 2004
Volume 64, Issue 7 Supplement
  • Table of Contents
  • Index by Author

Sign up for alerts

Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Cancer Research article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
In vivo induction of tumor-specific CTL against CEA-antigens and MAGE-3 antigens expressed on human lung adenocarcinoma by using CEA gene therapy
(Your Name) has forwarded a page to you from Cancer Research
(Your Name) thought you would be interested in this article in Cancer Research.
Citation Tools
In vivo induction of tumor-specific CTL against CEA-antigens and MAGE-3 antigens expressed on human lung adenocarcinoma by using CEA gene therapy
Masaji Okada, Takao Tanaka, Yoko Kita, Sachiko Kuwayama, Yumiko Muraki, Noriko Kanamaru, Satomi Hashimoto, Hiroko Takai, Chika Okada, Yukari Fukunaga, Yayoi Sakaguchi, Izumi Furukawa, Kyoko Yamada, Satoru Yamamoto, Akihide Matsumura, Keiji Iuchi, Masaaki Kawahara and Sakatani Mitsunori
Cancer Res April 1 2004 (64) (7 Supplement) 1185-1186;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
In vivo induction of tumor-specific CTL against CEA-antigens and MAGE-3 antigens expressed on human lung adenocarcinoma by using CEA gene therapy
Masaji Okada, Takao Tanaka, Yoko Kita, Sachiko Kuwayama, Yumiko Muraki, Noriko Kanamaru, Satomi Hashimoto, Hiroko Takai, Chika Okada, Yukari Fukunaga, Yayoi Sakaguchi, Izumi Furukawa, Kyoko Yamada, Satoru Yamamoto, Akihide Matsumura, Keiji Iuchi, Masaaki Kawahara and Sakatani Mitsunori
Cancer Res April 1 2004 (64) (7 Supplement) 1185-1186;
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics
Advertisement

Related Articles

Cited By...

More in this TOC Section

  • Rapamycin inhibits the development of gallbladder adenocarcinoma in BK5.erbB2 transgenic mice
  • Anti-cancer activity of N-heterocyclic indolyl glyoxylamides
  • In vivo inhibition of the mTOR pathway and reversal of Akt-dependent prostate intraepithelial neoplasia requires induction of mitochondrial pathway mediated cell-death
Show more Cellular, Molecular, and Tumor Biology 109: Preclinical Science and Imaging in Cancer Models
  • Home
  • Alerts
  • Feedback
Facebook  Twitter  LinkedIn  YouTube  RSS

Articles

  • Online First
  • Current Issue
  • Past Issues
  • Meeting Abstracts

Info for

  • Authors
  • Subscribers
  • Advertisers
  • Librarians
  • Reviewers

About Cancer Research

  • About the Journal
  • Editorial Board
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2018 by the American Association for Cancer Research.

Cancer Research Online ISSN: 1538-7445
Cancer Research Print ISSN: 0008-5472
Journal of Cancer Research ISSN: 0099-7013
American Journal of Cancer ISSN: 0099-7374

Advertisement